Janet Woodcock, acting FDA commissioner (Al Drago/Bloomberg via Getty Images)

FDA per­ma­nent­ly lifts in-per­son re­quire­ments for dis­pens­ing abor­tion pills

Since the pan­dem­ic be­gan, the FDA has al­lowed women to ac­cess the abor­tion drug mifepri­s­tone via the mail, mak­ing it eas­i­er for them and en­sur­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.